CN104958677A - 一种治疗膜性肾病的中药制剂及其制备方法 - Google Patents
一种治疗膜性肾病的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104958677A CN104958677A CN201510473122.7A CN201510473122A CN104958677A CN 104958677 A CN104958677 A CN 104958677A CN 201510473122 A CN201510473122 A CN 201510473122A CN 104958677 A CN104958677 A CN 104958677A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- radix
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 201000008350 membranous glomerulonephritis Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 206010018372 Glomerulonephritis membranous Diseases 0.000 title claims abstract description 33
- 231100000855 membranous nephropathy Toxicity 0.000 title claims abstract description 33
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 241000628997 Flos Species 0.000 claims description 18
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241000190633 Cordyceps Species 0.000 claims description 13
- 210000001320 hippocampus Anatomy 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 67
- 210000004185 liver Anatomy 0.000 abstract description 52
- 230000000694 effects Effects 0.000 abstract description 45
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 235000006533 astragalus Nutrition 0.000 abstract description 4
- 241000382455 Angelica sinensis Species 0.000 abstract description 3
- 241000045403 Astragalus propinquus Species 0.000 abstract description 3
- 241000804384 Cynomorium songaricum Species 0.000 abstract description 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract description 2
- 240000003915 Lophatherum gracile Species 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract description 2
- 241000218231 Moraceae Species 0.000 abstract description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract description 2
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 2
- 244000237330 gutta percha tree Species 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241000283220 Odobenus rosmarus Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000010975 amethyst Substances 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 41
- 210000004369 blood Anatomy 0.000 description 38
- 230000007812 deficiency Effects 0.000 description 32
- 239000000796 flavoring agent Substances 0.000 description 26
- 235000019634 flavors Nutrition 0.000 description 26
- 235000009508 confectionery Nutrition 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 17
- 229940079593 drug Drugs 0.000 description 17
- 230000036407 pain Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 230000008093 supporting effect Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 201000001881 impotence Diseases 0.000 description 8
- 230000027939 micturition Effects 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 206010017553 Furuncle Diseases 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000010228 Erectile Dysfunction Diseases 0.000 description 5
- 208000009205 Tinnitus Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000003127 knee Anatomy 0.000 description 5
- 210000000629 knee joint Anatomy 0.000 description 5
- 201000008383 nephritis Diseases 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 231100000886 tinnitus Toxicity 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 208000008967 Enuresis Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 241000005787 Cistanche Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 240000007164 Salvia officinalis Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- -1 Beracilline Chemical compound 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019705 Hepatic pain Diseases 0.000 description 2
- 241001559542 Hippocampus hippocampus Species 0.000 description 2
- 241001559417 Hippocampus trimaculatus Species 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000010436 fluorite Substances 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(2r,3s,4r,5s)-5-[(1r,2r,3s,5r,6s)-3,5-diamino-2-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- HARGZZNYNSYSGJ-UHFFFAOYSA-N 1,2 dihydrotanshinquinone Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)CO1 HARGZZNYNSYSGJ-UHFFFAOYSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000133570 Berberidaceae Species 0.000 description 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000660877 Coridius Species 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 244000084791 Curculigo orchioides Species 0.000 description 1
- 241000499399 Cynomoriaceae Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- HARGZZNYNSYSGJ-JTQLQIEISA-N Dihydrotanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2[C@@H](C)CO1 HARGZZNYNSYSGJ-JTQLQIEISA-N 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 241000729170 Dipsacus asper Species 0.000 description 1
- 241001050741 Dipsacus asperoides Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241001362421 Epimedium brevicornu Species 0.000 description 1
- 241000893531 Epimedium koreanum Species 0.000 description 1
- 241001660849 Epimedium pubescens Species 0.000 description 1
- 241001362411 Epimedium sagittatum Species 0.000 description 1
- 241001362415 Epimedium wushanense Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000001204 Hashimoto Disease Diseases 0.000 description 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241001478425 Hippocampus japonicus Species 0.000 description 1
- 241001478424 Hippocampus kuda Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241000173699 Lonicera dasystyla Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000003250 Mixed connective tissue disease Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000431987 Neocheiropteris fortunei Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000196124 Polypodiaceae Species 0.000 description 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241000501113 Sargentodoxa cuneata Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241001247203 Syngnathidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000009613 breast lymphoma Diseases 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- KXNYCALHDXGJSF-UHFFFAOYSA-N dihydroisotanshinone I Natural products CC1=CC=CC2=C(C(C=3OCC(C=3C3=O)C)=O)C3=CC=C21 KXNYCALHDXGJSF-UHFFFAOYSA-N 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002222 fluorine compounds Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960001639 penicillamine Drugs 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗膜性肾病的中药制剂,它是由当归、熟地黄、川芎、炒白芍、补骨脂、续断、杜仲、枸杞子、淫羊藿、黄芪、仙茅、骨碎补、冬虫夏草、益智仁、锁阳、紫石英、海马、丹参、红藤、蒲公英、金银花、淡竹叶、女贞子、桑葚、山茱萸按照一定的重量配比制成,具有补益肝肾、补肾壮阳、益精填髓的功效,治疗效果显著。
Description
技术领域
本发明涉及一种中药制剂,具体涉及一种治疗膜性肾病的中药制剂,本发明还涉及该中药制剂的制备方法。
背景技术
膜性肾病(membranous nephropathy,MN)病理特点是肾小球基底膜上皮细胞下弥漫的免疫复合物沉积伴基底膜弥漫增厚。临床以肾病综合征(NS)或无症状性蛋白尿为主要表现。膜性肾病(membranous nephropathy,MN)又称膜性肾小球肾炎(membranous glomerulonep hritis),膜性肾病可为原发性,亦可继发于多种疾病,见于感染(乙、丙型肝炎病毒)系统性疾病(如红斑狼疮)、药物治疗(如金、青霉胺等)以及恶性肿瘤。该病具有病程反复、慢性迁延的特点。
膜性肾炎在任何年龄均可发病,但以成人多见,80%以上患者发病年龄超过30岁,高峰在36~40岁男女发膜性肾病病之比为1.5∶1,成人男性稍多于女性,儿童男性较多。此病的发病原因主要有:1、免疫性疾病,系统性红斑狼疮,类风湿性关节炎,糖尿病,桥本甲状腺炎,Graves病,混合性结缔组织病,舍格伦综合征,原发性胆汁性肝硬化,强直性脊柱炎和急性感染性多神经炎。2、感染:乙型肝炎,丙型肝炎,梅毒,麻风,丝虫病,血吸虫病和疟疾。3、药物及毒物 有机金,汞,D-青霉胺,卡托普利和丙磺舒。4、肿瘤 肺癌,结肠癌,乳腺癌和淋巴瘤。5、其他,结节病,移植肾再发,镰状细胞病和血管淋巴样增生(Kimura病),但75%的膜性肾病找不到上述原因,即属于原发性膜性肾病。
目前针对膜性肾病的治疗一般是使用糖皮质激素以及细胞毒药物,但是这些药物本身存在着比较大的毒副作用,由于膜性肾炎是一个病程较长的慢性病,长期服用以上药物,会加重患者的肾脏负担,不利于患者的恢复,并且还增加了患者家庭的经济负担,患者不易接受。
发明内容
本发明的目的在于提供一种治疗膜性肾病的中药制剂,该中药制剂对于膜性肾病具有治疗效果明显,不易复发,价格低廉,无毒副作用,服用方便的特点。
本发明的另一目的是提供该治疗膜性肾病的中药制剂的制备方法。
发明人在多年的临床医疗实践中,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出一种治疗膜性肾病的中药制剂的新配方,本发明选择当归、熟地黄、川芎、炒白芍、补骨脂、续断、杜仲、枸杞子、淫羊藿、黄芪、仙茅、骨碎补、冬虫夏草、益智仁、锁阳、续断、紫石英、海马、丹参、川芎、红藤、蒲公英、金银花、淡竹叶、女贞子、桑葚、山茱萸进行组合,将这些药物组合使得各药物功效产生协同作用,使之具有补益肝肾、补肾壮阳、益精填髓的功效从而能够有效治疗膜性肾病。
本发明中药物的作用:
其中:
当归:为伞形科植物当归 Angelica sinensis (Oliv.) Diels 的干燥根。性味:甘、辛、苦,温。归肝、心、脾经。功效:补血;活血;调经止痛;润燥滑肠。当归对中枢神经系统有抑制作用,挥发油有镇静、催眠、镇痛、麻醉等作用。用于血虚萎黄、眩晕心悸、虚寒腹痛、风湿痹痛、跌扑损伤、痈疽疮疡。据《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用。
熟地黄:为玄参科植物地黄(Rehmannia glutinosa(Gdertn) Iibosch.ex Fisch. et Mey.)的块根经加工炮制而成。性味:甘、微温。归肝、肾经。功效:滋阴补血,益精填髓。用于肝肾阴虚,腰膝酸软,骨蒸潮热,盗汗遗精,内热消渴,血虚萎黄,心悸怔忡,月经不调,崩漏下血,眩晕,耳鸣,须发早白。熟地能补血滋阴而养肝益肾,凡血虚阴亏、肝肾不足所致的眩晕,均可应用。补血常与当归、白芍等同用;补肝肾常与山茱萸等同用。
川芎:为伞形科植物川芎Ligusticum chuanxiong Hort.的干燥根茎。性味:辛,温。归肝、胆、心经。功效:活血行气,祛风止痛。本品辛散温通,能上行巅顶,下达血海,外彻皮毛,旁通四肢,既能活血又能行气,昔人谓川芎为血中之气药,殆言其寓辛散、解郁、通达、止痛等功能。川芎有明显的镇静作用。抗菌作用等体外试验:川芎对大肠、痢疾(宋内氏)、变形、绿脓、伤寒、副伤寒杆菌及霍乱弧菌等有抑制作用。川芎水浸剂(1:3)在试管内对某些致病性皮肤真菌也有抑制作用。
炒白芍:为双子叶植物毛茛科植物芍药Paeonia lactiflora Pall. 的干燥根。性味:凉,苦酸,微寒。功效:补血柔肝、平肝止痛,敛阴收汗。研究表明:白芍中含有的芍药甙有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、抗溃疡、调节血糖的作用。白芍煎剂能抑制痢疾杆菌、肺炎链球菌、大肠杆菌、伤寒杆菌、溶血性链球菌、绿脓杆菌等。本品能养肝血、敛肝阴、抑肝阳、疏肝气,又能缓挛急、止疼痛,为治疗肝经各种疼痛之良药。
补骨脂:为豆科植物补骨脂Psoralea corylifolia L.的果实。性味:辛、苦,温。归肾、脾经。功效:补肾壮阳,固精缩尿,温脾止泻,纳气平喘。本品能补肾阳、暖脾阳,止泄泻,为治脾肾阳虚之要药。本品辛苦温燥,能温补命门,补肾强腰,壮阳、固精、缩尿,为治肾阳不足、下元不固之要药。
续断:为川续断科植物川续断Dipsacus asperoides C. Y. Cheng et T. M. Ai (或Dipsacus asper Wall)的干燥根。性味:苦、辛、微温。归肝、肾经。功效:补肝肾;强筋骨;调血脉;止崩漏,本品甘温助阳,辛温散寒,用治肾阳不足,下元虚冷,阳痿不举,遗精滑泄,遗尿尿频等症,兼有补益肝肾,强健壮骨,通利血脉之功。常与肉苁蓉,菟丝子等壮阳药同用。
杜仲:为杜仲科植物杜仲(Eucommia ulmoides Oliver)的干燥树皮。性味:甘,温。归肝、肾、胃经。功效:补益肝肾、强筋壮骨、调理冲任、固经安胎。《本草纲目》:杜仲,古方只知滋肾,惟王好古言是肝经气分药,润肝燥,补肝虚,发昔人所未发也。盖肝主筋,肾主骨,肾充则骨强,肝充则筋健,屈伸利用,皆属于筋。
枸杞子:为茄科植物宁夏枸杞Lycium barbarum L. 的干燥成熟果实。性味:甘、平。归肝、肾经。功效:滋补肝肾、益精明目。主治:肝肾亏虚;头晕目眩;目视不清;腰膝酸软;阳痿遗精;虚劳咳嗽;消渴引饮。枸杞子含有丰富的胡萝卜素、维生素A1、B1、B2、C等钙、铁等健康眼睛的必需营养,故擅长明目,所以俗称“明眼子”。历代医家治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症,常常使用枸杞子。
淫羊藿:为小檗科植物淫羊藿Epimedium brevicornum Maxim.、箭叶淫羊藿Epimedium sagittatum (Sieb.et Zucc.)Maxim. 、柔毛淫羊藿Epimedium pubescens Maxim.、巫山淫羊藿Epimedium wushanense T.S.Ying、或朝鲜淫羊藿Epimedium koreanum Nakai的干燥地上部分。性味:辛、甘,温。归肝、肾经。功效:补肾壮阳,祛风除湿。《本经》:主阴痿绝伤,茎中痛。利小便,益气力,强志。
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,微温。归肺、脾、肝、肾经。功效:补气升阳、固表敛汗、利水消肿、托疮排脓、通调水道。在《本草汇言》中有记载:“黄芪,补肺健脾,实卫敛汗,驱风运毒之药也。故阳虚之人,自汗频来,乃表虚而腠理不密也,黄芪可以实卫而敛汗;伤寒之证,行发表而邪汗不出,乃里虚而正气内乏也,黄芪可以济津以助汗;贼风之疴,偏中血脉而手足不随者,黄芪可以荣筋骨;痈疡之证,脓血内溃,阳气虚而不敛者,黄芪可以生肌肉,又阴疮不能起发,阳气虚而不愈者,黄芪可以生肌肉。”本品在体外对志贺氏痢疾杆菌、炭疽杆菌、甲型溶血性链球菌、乙型溶血性链球菌、白喉杆菌、假白喉杆菌、肺炎双球菌、金黄色葡萄球菌、柠檬色葡萄球菌、枯草杆菌等均有抑制作用。黄芪擅长补中益气,为补气升阳的要药,并且补气利尿,以消肿。另外用黄芪治疗慢性肾炎有一定的疗效。
仙茅:为石蒜科植物仙茅Curculigo orchioides Gaertn. 的干燥根茎。性味:辛,温,有毒。入肾、肝经。功效:补肾阳,强筋骨,散寒湿。仙茅水提取液有兴奋性机能的作用。仙茅有增强免疫功能的作用。仙茅辛热,能补肾阳,兴阳道,止遗尿,常与淫羊藿、菟丝子同用。淫羊藿辛甘性温,温燥之性较强,补名门之火,祛风湿疏通络作用突出,长于治疗风湿痹痛,四肢麻木等,仙茅辛热有毒,暖腰膝、祛寒湿作用突出。仙茅与淫羊藿相须为用温阳补肾,用于肾阳不足、命门火衰的阳痿精冷,以及肾虚腰膝痿软,筋骨冷痛。
骨碎补:为水龙骨科植物槲蕨Drynaria fortunei (Kunze) J. Sm.的干燥根茎。全年均可采挖,除去泥沙,干燥,或再燎去茸毛(鳞片)。性味:苦,温。归肾、肝经。功效:补肾强骨,续伤止痛。用于肾虚腰痛,耳鸣耳聋,牙齿松动,跌扑闪挫,筋骨折伤;外治斑秃,白癜风。
冬虫夏草:为麦角菌科真菌冬虫夏草菌Cordyceps sinensis (Berk.)Sacc. 寄生在蝙蝠蛾科昆虫幼虫上的子座及幼虫尸体的复合体。性味:甘,平。归肺、肾经。功效:补肺益肾,止血化痰。用于久咳虚喘,劳嗽咯血,阳痿遗精,腰膝酸痛。《重庆堂随笔》:冬虫夏草,具温和平补之性,为虚疟、虚痞、虚胀、虚痛之圣药,功胜九香虫。凡阴虚阳亢而为喘逆痰嗽者,投之悉效,不但调经种子有专能也。周稚圭先生云,须以秋分日采者良。雄谓夏取者可治阳气下陷之病。
益智仁:为姜科草本植物益智的成熟果实。性味:辛、温、归肾、脾经。功能:温补固摄,暖脾止泻,固唌摄唾,温肾固精缩尿。主治脾肾虚寒,腹痛腹泻;或肾气虚寒小便频数,遗尿,遗精,白浊;或脾胃虚寒所致的慢性泄泻及口中唾液外流而不能控制者。
锁阳:为锁阳科植物锁阳Cynomorium songaricum Rupr.的干燥肉质茎。性味:甘,温。归脾、肾、大肠经。功效:补肾阳,益精血,润肠通便。用于腰膝痿软,阳痿滑精,肠燥便秘。《本草求真》:锁阳,本与苁蓉同为一类。凡阴气虚损,精血衰败,大便燥结,治可用此以啖,并代苁蓉,煮粥弥佳,则知其性虽温,其体仍润,未可云为命门火衰必用之药也。故书有载大便不燥结者勿用,益知性属阴类,即有云可补阳,亦不过云其阴补而阳自兴之意,岂真性等附、桂而为燥热之药哉。
紫石英:本品为氟化物类矿物萤石族萤石,主含氟化钙 (CaF2)。性味:甘,温。归心、肺、肾经。功效:镇心安神,温肺,暖宫。用于失眠多梦,心悸易惊,肺虚咳喘,宫寒不孕。《纲目》:紫石英上能镇心,重以去怯也。下能益肝,湿以去枯也。心主血,肝藏血,其性暖而补,故心神不安,肝血不足及女子血海虚寒不孕者宜之。
海马:为海龙科动物线纹海马 Hippocampus kelloggi Jordan et Snyder、刺海马 Hippocampus histrix Kaup 、大海马 Hippocampus kuda Bleeker 、三斑海马Hippocampus trimaculatus Leach 或小海马(海蛆) Hippocampus japonicus Kaup的干燥体。性味:甘,温。归肝、肾经。功效:温肾壮阳,散结消肿。用于阳痿,遗尿,肾虚作喘,症瘕积聚,跌扑损伤;外治痈肿疔疮。《纲目》:暖水藏,壮阳道,消瘕块,治疔疮肿毒。
丹参:为双子叶植物唇形科Labiatae鼠尾草属植物丹参Salvia /miltiorrhizaBge的干燥根及根茎。性味:苦,微寒。归经:入心、肝经。功效:活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神。用于胸肋胁痛,风湿痹痛,症瘕结块。《日华子本草》:养神定志,通利关脉。治冷热劳,骨节疼痛,四肢不遂;排脓止痛,生肌长肉;破宿血,补新生血;安生胎,落死胎;止血崩带下,调妇人经脉不匀,血邪心烦;恶疮疥癣,瘿赘肿毒,丹毒;头痛,赤眼,热温狂闷。丹参制剂中含有隐丹参酮、二氢丹参酮,对体外的葡萄球菌、大肠杆菌、变性杆菌有抑制作用。
红藤:为木通科植物大血藤 Sargentodoxa cuneata (Oliv.) Rehd. et wils. 的干燥藤茎。性味:苦、平。归肝、大肠经。功效:败毒消痈,活血通络,祛风杀虫,抑菌作用。清热解毒,活血,祛风。用于肠痈腹痛、经闭痛经、风湿痹痛、跌打扑痛。临床上对急、慢性阑尾炎,阑尾脓肿有较好疗效。
蒲公英:蒲公英又称尿床草,为菊科植物蒲公英Toraxacum mongolicum Hand. Mazz.、碱地蒲公英Toraxacum borealisinense Kitam. 或同属数种植物的干燥全草。性味:甘、微苦、寒。归肝、胃经。功效:清热解毒,消肿散结。蒲公英具有消炎、抗菌、抗肿瘤、清热解毒的功效,现代临床上应用范围广,作用好。用于疔疮肿毒,乳痈,瘰疠,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。对热毒所致的乳痈肿痛、疔疮有良好的效果,可单独煎汁内服,或外敷局部;也可配合其它清热解毒药同用,如银花、连翘、地丁草、野菊花、赤芍等。
金银花:为忍冬科植物忍冬Lonicera japonica Thunb.、红腺忍冬Lonicera hypoglauca Miq.、山银花(毛萼忍冬)Lonicera confusa DC. 或毛花柱忍冬Lonicera dasystyla Rehd.的干燥花蕾或带初开的花。性味:甘、寒。归肺、心、胃经。功效:清热解毒,疏风散热。本品性味甘寒,既能清热解毒,又善散痈消肿,为治疗一切阳证痈肿疔疮的要药。临床上用于痈疽疔毒:常与紫地丁、野菊花等同用,能增强清热解毒作用,可用以痈疽疔毒,红肿疼痛。
淡竹叶:为禾本科植物淡竹叶Lophatherum gracile Brongn. 的干燥茎叶。性味:甘、淡,寒。归心、胃、小肠经。清热除烦,利尿。用于热病烦渴,小便赤涩淋痛,口舌生疮。本品上能清心火而解热,下能降小肠火而利尿,能使火热之邪下行,从小便而清,因此可用于心火上炎之口舌生疮,以及心热下移小肠所致的小便短赤涩痛,常配木通、生地等。
女贞子:为木犀科植物女贞Ligustrum lucidum Ait. 的干燥成熟果实。性味:苦甘、平、无毒。归肝,肾,肺经。功效:补肝肾,强腰膝。主治:阴虚内热,头晕,目花,耳鸣,腰膝酸软,须发早白。现代药理学研究:女贞子可增强非特异性免疫功能,对异常的免疫功能具有双向调节作用;对化疗和放疗所致的白细胞减少有升高作用;可降低实验动物的血清胆固醇,有预防和消减动脉粥样硬化斑块和减轻斑块厚度的作用,能减少冠状动脉粥样硬化病变数并减轻其阻塞程度;能明显降低高龄鼠脑、肝中丙二醛含量,提高超氧化物歧化酶(SOD)活性,具一定抗衰老应用价值;有强心、利尿、降血糖及保肝作用;并有止咳、缓泻、抗菌、抗肿瘤作用。
桑葚:为桑科落叶乔木植物桑Morus alba L.的干燥果穗。性味:甘、酸、寒。归肝、肾、心经。功效:滋阴养血;生津;润肠。主肝肾不足和血虚精亏的头晕目眩;腰酸耳鸣;须发早白;失眠多梦;津伤口渴;消渴;肠燥便秘;关节不利。现代研究证实,桑葚子中含有丰富的葡萄糖、蔗糖、胡萝卜素、维生素、苹果酸、酒石酸,磷质等丰富的营养成份,并含有丰富的活性蛋白,常吃能显著提高人体免疫力,桑葚子具有延缓衰老、驻容养颜之功效。《本草经疏》:桑椹,甘寒益血而除热,为凉血补血益阴之药,消渴由于内热,津液不足,生津故止渴。五脏皆属阴,益阴故利五脏。阴不足则关节之血气不通,血生津满,阴气长盛,则不饥而血气自通矣。热退阴生,则肝心无火,故魂安而神自清宁,神清则聪明内发,阴复则变白不老。甘寒除热,故解中酒毒。性寒而下行利水,故利水气而消肿。
山茱萸:为山茱萸科植物山茱萸Cornus officinalis Sieb. et Zucc. 的干燥成熟果肉。性味:酸、涩,微温。归肝、肾经。功效:补益肝肾,涩精固脱。主治头晕目眩,耳聋耳鸣,腰膝酸软,遗精滑精,小便频数,虚汗不止,妇女崩漏。山茱萸微温不燥,补而不峻,能平补阴阳,养髓荣筋,为治肝肾不足所常用。如属肝阴虚,眩晕耳鸣,骨蒸潮热,腰膝酸软,此外,本品能补肾纳气,且有酸敛之功,可免肺气耗散,常与五味子配伍,在补肺纳肾剂中使用,治疗肾气虚喘。治肾阳不足,阳痿、遗精、遗尿,山茱萸可与补骨脂等药同用,以温补肾气,固精缩尿。
本发明的方解是:方中当归补血活血,熟地黄滋阴补血、益精填髓,川芎活血行气,炒白芍补血柔肝、平肝止痛,补骨脂补肾壮阳,续断、杜仲补益肝肾、强筋壮骨,以上七味共为君药,首先从患者身体的根本上进行补益肝肾、补肾壮阳,滋养患者肾脏,并且可以治疗因膜性肾病所带来的肾功能衰竭、肾炎等症状,从而达到彻底治疗的目的。枸杞子滋补肝肾、益精明目,淫羊藿、仙茅补肾壮阳,黄芪补气升阳,骨碎补补肾强骨,冬虫夏草补肺益肾,益智仁、锁阳温补固摄,以上八味共为臣药,增加君药的药效,加强滋养肝肾的作用,加快病情的好转。紫石英镇心安神,海马温肾壮阳、散结消肿,丹参凉血消痈,红藤凉血消痈,蒲公英、金银花清热解毒、消肿散结,淡竹叶清热除烦,女贞子补肝肾,桑葚滋阴养血,山茱萸补益肝肾,以上几味共为佐药,由于膜性肾炎是慢性疾病,佐药缓慢的进行对身体的儒养,加强对患者身体的调理,从而促进患者的恢复。此方诸药合用,君臣协力,佐使共辅,具有补益肝肾、补肾壮阳、益精填髓的功效,能够有效治疗膜性肾病。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:当归10-20份、熟地黄13-23份、川芎7-17份、炒白芍10-20份、补骨脂13-23份、续断15-25份、杜仲15-25份、枸杞子19-29份、淫羊藿15-25份、黄芪25-35份、仙茅10-20份、骨碎补10-20份、冬虫夏草3-9份、益智仁10-20份、锁阳10-20份、紫石英10-20份、海马3-9份、丹参15-25份、红藤15-25份、蒲公英15-25份、金银花10-20份、淡竹叶7-17份、女贞子7-17份、桑葚7-17份、山茱萸7-17份。
其中优选为:当归15份、熟地黄18份、川芎12份、炒白芍15份、补骨脂18份、续断20份、杜仲20份、枸杞子24份、淫羊藿20份、黄芪30份、仙茅15份、骨碎补15份、冬虫夏草6份、益智仁15份、锁阳15份、紫石英15份、海马6份、丹参20份、红藤20份、蒲公英20份、金银花15份、淡竹叶12份、女贞子12份、桑葚12份、山茱萸12份。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂,如丸剂、散剂、片剂、口服液等。例如可以将这些原料药研成粉末混合均匀制成散剂冲服;可以用水煎,经过滤得滤液,加入防腐剂制成口服液;必要时也可以直接服用汤剂。
本发明优选的制备方法是汤剂,其制备方法如下:
步骤一:按本发明重量配比,将补骨脂、枸杞子、益智仁、女贞子、桑葚、山茱萸用纱布包成药包,放于水中浸泡40-45分钟,过滤,备用;
步骤二:按本发明重量配比,称取冬虫夏草、海马放入砂锅中,加水漫过药物4-5厘米,先用武火将水烧开,然后转为文火,煎煮20分钟,过滤,得滤液,找此方法反复熬煮3次,合并3次滤液,备用;
步骤三:按本发明重量配比,称取紫石英放入砂锅中,适当捣碎,加入步骤一中剩余的水漫过药物5-6厘米,先用武火将水烧开,然后转为文火,煎煮0.5小时,然后加入熟地黄、炒白芍、续断、杜仲、黄芪、仙茅、骨碎补、丹参放入锅中继续煎煮30-40分钟,过滤,得滤液,在剩余药渣中,加入3-4厘米的水,烧开,然后加入当归、川芎、淫羊藿、锁阳、红藤、蒲公英、淡竹叶以及步骤一中的药包煎煮15-20分钟,最后加入金银花煎煮10分钟,过滤,得滤液,备用;
步骤三:将步骤二和步骤三中的两次滤液进行合并,均匀混合,既得本发明所述的治疗膜性肾病的中药汤剂。
本发明药物具有补益肝肾、补肾壮阳、益精填髓的功效,且治疗效果明显,不易复发,价格低廉,无毒副作用,服用方便,据对临床180例患者观察统计,使用本发明药物一个疗程总有效率85%,两个疗程总有效率95%。
具体实施方式
实施例一、当归10份、熟地黄13份、川芎7份、炒白芍10份、补骨脂13份、续断15份、杜仲15份、枸杞子19份、淫羊藿15份、黄芪25份、仙茅10份、骨碎补10份、冬虫夏草3份、益智仁10份、锁阳10份、紫石英10份、海马3份、丹参15份、红藤15份、蒲公英15份、金银花10份、淡竹叶7份、女贞子7份、桑葚7份、山茱萸7份。
实施例二、当归15份、熟地黄18份、川芎12份、炒白芍15份、补骨脂18份、续断20份、杜仲20份、枸杞子24份、淫羊藿20份、黄芪30份、仙茅15份、骨碎补15份、冬虫夏草6份、益智仁15份、锁阳15份、紫石英15份、海马6份、丹参20份、红藤20份、蒲公英20份、金银花15份、淡竹叶12份、女贞子12份、桑葚12份、山茱萸12份。
实施例三、当归20份、熟地黄23份、川芎17份、炒白芍20份、补骨脂23份、续断25份、杜仲25份、枸杞子29份、淫羊藿25份、黄芪35份、仙茅20份、骨碎补20份、冬虫夏草9份、益智仁20份、锁阳20份、紫石英20份、海马9份、丹参25份、红藤25份、蒲公英25份、金银花20份、淡竹叶17份、女贞子17份、桑葚17份、山茱萸17份。
下面是患者使用本发明药物的临床统计资料:
一、一般资料
治疗膜性肾病患者180例。其中男性93例,女性87例,男女比例1.07:1,平均年龄36岁,病程时间不等。
二、治疗方法:
按照本发明药物实施例二,以及所选的制备方法制备的制剂,每日一剂,一天两次,30日为一个疗程。
三、疗效评定标准:
治愈:膜性肾病肾病所表现出来的蛋白尿、肾炎等症状完全消失,各项实验室检查均显示正常,三个月之内未见反复;
好转:膜性肾病的病情得到控制,临床症状基本消失,各项实验室检查均有所好转;
未愈:膜性肾病的临床症状无明显好转,甚至加重。
四、治疗结果统计
其中:总有效率=治愈率+好转率
通过治疗结果的统计表明,本发明中药在治疗膜性肾病方面具有良好的临床效果,能有效提高治疗的治愈率,值得在临床应用上推广。
典型病例及疗效:
病例一、患者王某,男,30岁,患者自述两个月前出现乏力,偶尔出现腹胀、腹痛的感觉,之后出现双下肢水肿,患者去多家医院检查,最终确诊为膜性肾病,患者决定采用中药的治疗方法,采用本发明实施例二中所制制剂,以及所选的制备方法,患者使用两个疗程后乏力、水肿的感觉明显消失,患者又坚持使用了两个疗程,体质明显加强,身体状况也逐渐得到恢复,去医院检查,各项指标均显示正常,随访三个月未见复发,痊愈。
病例二、患者张某,男,38岁,患者近期出现身体乏力,稍微活动一会就感觉身体吃不消,并且发现四肢有水肿的现象,患者去多家医院进行检查,最终确诊为膜性肾病,患者希望采用中医治疗方法,后来我处治疗,采用本发明实施例二中所制制剂,以及所有选的制备方法,使用两个疗程后患者乏力、水肿的现象明显缓解,体力也逐渐恢复,为防止复发,患者又坚持服用了两个疗程,之后患者去医院进行复查,身体各项指标显示正常,随访三个月,未见复发,痊愈。
Claims (4)
1.一种治疗膜性肾病的中药制剂,其特征在于,该中药制剂是由以下重量份的药物制成:当归10-20份、熟地黄13-23份、川芎7-17份、炒白芍10-20份、补骨脂13-23份、续断15-25份、杜仲15-25份、枸杞子19-29份、淫羊藿15-25份、黄芪25-35份、仙茅10-20份、骨碎补10-20份、冬虫夏草3-9份、益智仁10-20份、锁阳10-20份、紫石英10-20份、海马3-9份、丹参15-25份、红藤15-25份、蒲公英15-25份、金银花10-20份、淡竹叶7-17份、女贞子7-17份、桑葚7-17份、山茱萸7-17份。
2.根据权利要求1所述的治疗膜性肾病的中药制剂,其特征在于,由以下重量份的药物制成:当归15份、熟地黄18份、川芎12份、炒白芍15份、补骨脂18份、续断20份、杜仲20份、枸杞子24份、淫羊藿20份、黄芪30份、仙茅15份、骨碎补15份、冬虫夏草6份、益智仁15份、锁阳15份、紫石英15份、海马6份、丹参20份、红藤20份、蒲公英20份、金银花15份、淡竹叶12份、女贞子12份、桑葚12份、山茱萸12份。
3.根据权利要求1或2所述的治疗膜性肾病的中药制剂,其特征在于:所述中药制剂为汤剂。
4.一种治疗膜性肾病的中药制剂的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量配比,将补骨脂、枸杞子、益智仁、女贞子、桑葚、山茱萸用纱布包成药包,放于水中浸泡40-45分钟,过滤,备用;步骤二:按本发明重量配比,称取冬虫夏草、海马放入砂锅中,加水漫过药物4-5厘米,先用武火将水烧开,然后转为文火,煎煮20分钟,过滤,得滤液,找此方法反复熬煮3次,合并3次滤液,备用;步骤三:按本发明重量配比,称取紫石英放入砂锅中,适当捣碎,加入步骤一中剩余的水漫过药物5-6厘米,先用武火将水烧开,然后转为文火,煎煮0.5小时,然后加入熟地黄、炒白芍、续断、杜仲、黄芪、仙茅、骨碎补、丹参放入锅中继续煎煮30-40分钟,过滤,得滤液,在剩余药渣中,加入3-4厘米的水,烧开,然后加入当归、川芎、淫羊藿、锁阳、红藤、蒲公英、淡竹叶以及步骤一中的药包煎煮15-20分钟,最后加入金银花煎煮10分钟,过滤,得滤液,备用;步骤四:将步骤二和步骤三中的两次滤液进行合并,均匀混合,既得本发明所述的治疗膜性肾病的中药汤剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510473122.7A CN104958677A (zh) | 2015-08-05 | 2015-08-05 | 一种治疗膜性肾病的中药制剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510473122.7A CN104958677A (zh) | 2015-08-05 | 2015-08-05 | 一种治疗膜性肾病的中药制剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104958677A true CN104958677A (zh) | 2015-10-07 |
Family
ID=54212878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510473122.7A Pending CN104958677A (zh) | 2015-08-05 | 2015-08-05 | 一种治疗膜性肾病的中药制剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104958677A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853678A (zh) * | 2016-04-21 | 2016-08-17 | 陕西中医药大学附属医院 | 一种治疗膜性肾病的中药组合物及其制备方法 |
| CN106139038A (zh) * | 2016-08-31 | 2016-11-23 | 臧建辉 | 一种治疗特发性膜性肾病的中药 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1695732A (zh) * | 2005-04-18 | 2005-11-16 | 俞锋 | 双肾同补胶囊及其制备方法 |
| CN1781538A (zh) * | 2004-12-02 | 2006-06-07 | 上海方心科技研究所 | 治疗肾炎及肾病综合症的中药制剂 |
| CN101152414A (zh) * | 2007-09-30 | 2008-04-02 | 甘志球 | 一种治疗慢性肾炎、肾病综合征的中药制剂 |
| CN104013765A (zh) * | 2014-05-20 | 2014-09-03 | 柳晖 | 一种治疗肝肾阴虚的中药组合物 |
-
2015
- 2015-08-05 CN CN201510473122.7A patent/CN104958677A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1781538A (zh) * | 2004-12-02 | 2006-06-07 | 上海方心科技研究所 | 治疗肾炎及肾病综合症的中药制剂 |
| CN1695732A (zh) * | 2005-04-18 | 2005-11-16 | 俞锋 | 双肾同补胶囊及其制备方法 |
| CN101152414A (zh) * | 2007-09-30 | 2008-04-02 | 甘志球 | 一种治疗慢性肾炎、肾病综合征的中药制剂 |
| CN104013765A (zh) * | 2014-05-20 | 2014-09-03 | 柳晖 | 一种治疗肝肾阴虚的中药组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 陆向然 等: "补益肝肾中药治疗绝经妇女骨密度降低疗效观察", 《实用中医药杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853678A (zh) * | 2016-04-21 | 2016-08-17 | 陕西中医药大学附属医院 | 一种治疗膜性肾病的中药组合物及其制备方法 |
| CN106139038A (zh) * | 2016-08-31 | 2016-11-23 | 臧建辉 | 一种治疗特发性膜性肾病的中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN103520621B (zh) | 一种治疗老年性白内障的中药组合物及其制备方法 | |
| CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
| CN104352776A (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
| CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN104524287A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法 | |
| CN104324340B (zh) | 一种治疗跟骨骨质增生的中药制剂及其制备方法 | |
| CN104306540B (zh) | 一种治疗脑瘤术后肢体麻木的中药制剂及其制备方法 | |
| CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
| CN104873828A (zh) | 一种治疗放射性皮肤损伤的中药制剂及其制备方法 | |
| CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
| CN103977281A (zh) | 一种治疗女性内分泌失调的中药组合物及其制备方法 | |
| CN104984027A (zh) | 一种治疗骨髓增生异常综合征的中药制剂及其制备方法 | |
| CN104958677A (zh) | 一种治疗膜性肾病的中药制剂及其制备方法 | |
| CN104906430A (zh) | 一种治疗干眼症的中药制剂及其制备方法 | |
| CN105412899A (zh) | 一种用于缓解红斑性肢痛病的中药制剂及其制备方法 | |
| CN104815232A (zh) | 一种治疗原发性肺动脉高压的中药制剂及其制备方法 | |
| CN104906507A (zh) | 一种降低血压、调理体质的中药组合物 | |
| CN104398997A (zh) | 一种用于局限性硬皮病的中药组合物及其制备方法 | |
| CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
| CN104940752A (zh) | 一种治疗外阴溃疡的中药制剂及其制备方法 | |
| CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
| CN105663601A (zh) | 一种治疗缩窄性心包炎的中药制剂及其制备方法 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151007 |